AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ABEV
ACCE-researched

Ambev S.A. American Depositary Shares (Each representing 1 Common Share) (ABEV) fair value

Consumer Defensive · Beverages - Brewers · NYSE · United States
$3.30-0.90%
Market cap $51.3BNext earnings 2026-10-29Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 18% below our fair value
Price
$3.30
Model fair valueConfidence: good
$4.04
Model range
$2.22 to $5.86
Fair value $4.04
Price $3.30
5 models fit Ambev S.A. American Depositary Shares (Each representing 1 Common Share) and they partly agree: 3 of 5 land within 15% of the average.
Two or more of our models back this value.
Discount(i)Silver73
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionAmbev S.A. American Depositary Shares (Each representing 1 Common Share) (ABEV)
Fair value (5 models)
$4.04
ACCE price target
$3.36
Rating
Undervalued
Horizon
12 months
Fair value published on 19 Oct 2026, 19:04 CEST; previously $5.05 since 15 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $3.50 since 6 May 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $3.30 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
18.2% below
+22.3% to fair value
ACCE score
77
out of 100
Analysts
27% buy
11 covering
P/E
17.5x
forward 13.2x
1-year return
+49.3%
Dividend yield
4.07%

Ambev S.A. American Depositary Shares (Each representing 1 Common Share) in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Ambev is the Brazilian brewer behind Brahma, Skol and Antarctica, and it also bottles Pepsi, Gatorade and Lipton under franchise deals across much of Latin America. Its moat is distribution density: a beer cooler in every corner store and bar across Brazil, backed by scale in aluminum and glass packaging that smaller rivals cannot match. Top-line growth has nearly stalled at 0.3%, so the case rests on margin and cash generation rather than volume expansion, with a 51.9% gross margin and 23.7% operating margin still well above most global peers. At 13.2x forward earnings against 17.2x trailing, the market is pricing in a meaningful earnings recovery that management needs to deliver. For a portfolio manager, the question is whether the defensive franchise and an ROE of 18.4% justify a deeper look at whether top-line stagnation is cyclical or structural.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Sequential revenue decline
    QoQ revenue fell 10.3% despite YoY growth of 0.3%, signalling recent momentum loss or seasonal weakness that warrants monitoring.
  • moderate
    Earnings growth disconnect
    YoY earnings up 24.6% while revenue flat at 0.3% suggests margin expansion or one-time items; sustainability unclear given QoQ revenue drop.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Strong historical growth of 8.6% annually over five years shows resilient demand despite current slowdown.
  • Net margin of 18.4% and ROE of 18.4% demonstrate efficient capital deployment and pricing power.
  • Free cash flow yield of 8.1% with minimal debt at 0.06x equity supports sustainable dividends.
Why it could disappoint
  • Revenue growth has collapsed to 0.3% year over year, signaling demand weakness in core markets.
  • Forward P/E of 13.2x appears cheap but analyst consensus is weak with only 27% buy ratings.
  • Latest earnings matched expectations exactly at zero surprise, indicating no positive momentum.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ABEV's valuation models land
Price
$3.30
Model fair value
$4.04
Model range
$2.22 to $5.86
Fair value $4.04
Price $3.30
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish27% buy · 11 covering analysts
● Strong buy 1● Buy 2● Hold 5● Sell 1● Strong sell 2
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+0.3%
1 month
+12.6%
3 months
+7.8%
6 months
+14.6%
YTD
+33.6%
1 year
+49.3%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 19:04 CESTRatingUndervaluedfirst publication$3.29
19 Oct 2026, 19:04 CESTFair value$4.04$5.05$3.29
18 Oct 2026, 00:00 CESTACCE price target$3.36$3.50$3.29
15 Oct 2026, 00:00 CESTFair value$5.05$4.09$3.22
7 Oct 2026, 00:00 CESTFair value$4.09$3.92$3.25
5 Oct 2026, 00:00 CESTFair value$3.92$4.05$2.99
1 Oct 2026, 00:00 CESTFair value$4.05$3.97$2.88
28 Sept 2026, 00:00 CESTFair value$3.97$4.14$2.91
26 Sept 2026, 00:00 CESTFair value$4.14$4.08$2.91
14 Sept 2026, 00:00 CESTFair value$4.08$4.26$3.02

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ABEV page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth47Value87Quality84Momentum90Total77
Valuation
Trailing P/E
17.5x
Forward P/E
13.2x
PEG
0.71
P/B
2.68x
EV / Revenue
2.5x
Book value/sh
BRL 1.14
Enterprise value
$43.2B
Profitability
ROE
18.4%
FCF yield
7.67%
ROIC
13.6%
Health and risk
Debt / equity
0.06
Dividend yield
4.07%
Beta
0.22

Price

+50.7% · 1Y

Ask anything about ABEV

Answered from Ambev S.A. American Depositary Shares (Each representing 1 Common Share) fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 67% of peers
low 9.2x17.5xhigh 20.2x
ROEbetter than 67% of peers
low 11%18%high 24%
Div yieldbetter than 100% of peers
low 0.0%4.1%high 4.1%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ABEV Ambev S.A. American Depositary Shares (Each representing 1 Common Share)$3.30$418% below17.5x18.4%8477
FEMSAUBD.MX Fomento Economico MexicanoMXN 240.21MXN 15456% above18.7x14.8%6172
HEIA.AS Heineken€77.52€719% above18.9x12.1%5967
FMX Fomento Economico Mexicano S.A.B. de C.V. Common Stock$128.52$7180% above9.2x14.8%5670
STZ Constellation Brands Inc. Common Stock$138.68$1465% below12.4x24.0%8264
CARL-B.CO Carlsberg Bkr 968.40kr 9067% above20.2x20.4%6367
BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)$84.26$6530% above18.2x11.4%6977

Sector report card

Where ABEV ranks against its sector peers on each metric.

Computing percentiles…
40 filings
October 2026
Oct 22
6-KForeign current reportPeriod 2026-12-31
View on SEC →
Oct 14
6-KForeign current reportPeriod 2026-12-31
View on SEC →
Oct 9
6-KForeign current reportPeriod 2026-09-30
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR